Biotechnology
House Democrats press Walmart, Costco, Kroger to sell abortion pill mifepristone
In this photo illustration, packages of Mifepristone tablets are displayed at a family planning clinic on April 13, 2023 in Rockville, Maryland. Anna Moneymaker | Getty Images House Democrats on Thursday called on Walmart, Costco, Kroger, Safeway and Health Mart to publicly commit to sell the prescription abortion pill mifepristone at their retail pharmacies. Pending […]
Read More
Health insurance stocks slide after UnitedHealth warns more surgeries will drive up medical costs
Health insurer stocks dropped on Wednesday after UnitedHealth Group warned of higher medical costs as older Americans start to catch up on surgeries they delayed during the Covid pandemic. Shares of UnitedHealth, the largest U.S. healthcare provider by market value, closed around 6% lower. Medicare-focused insurer Humana declined 11%. Elevance Health closed roughly 7% lower, […]
Read More
Covid vaccine maker Novavax sees a pathway to survival – but it won’t be easy
Medical syringes and Novavax logo displayed in the background are seen in this illustration photo taken in Krakow, Poland on December 2, 2021. Jakub Porzycki | NurPhoto | Getty Images Novavax has a clear message for Wall Street: The cash-strapped Covid vaccine maker sees a pathway to survival. Maryland-based Novavax said as much last month […]
Read More
Eli Lilly CEO says Medicare price negotiations could harm drug development
David Ricks, CEO, Eli Lilly. Scott Mlyn | CNBC Eli Lilly CEO David Ricks on Tuesday said Medicare price negotiations, which aim to cut costs for older Americans, could potentially harm drug development. “I’m really worried about the harm this will do to new cures and possibilities in medicine,” Ricks said in an interview on […]
Read More
Illumina acquisition of Grail wins support from GOP lawmakers, state AGs as FTC tries to block
Rafael Henrique | Lightrocket | Getty Images Republican lawmakers, state attorneys general and several advocacy groups have voiced their support for Illumina’s acquisition of cancer test developer Grail while the Federal Trade Commission fights to unwind the deal. The groups filed 14 amicus briefs Monday urging the U.S. 5th Circuit Court of Appeals to reverse […]
Read More
Bernie Sanders vows to oppose NIH nominee until Biden delivers plan to lower drug prices
U.S. Senator Bernie Sanders (I-VT) speaks at a press conference on Capitol Hill about 11 Senate Democrats who sent a letter to President Joe Biden urging him to invoke the 14th Amendment to avoid a catastrophic debt default, in Washington, May 18, 2023. Evelyn Hockstein | Reuters Sen. Bernie Sanders vowed to oppose President Joe […]
Read More
One million people have lost Medicaid coverage since pandemic protections expired
A medical worker collects a swab sample from a woman at a COVID-19 testing site in New York, the United States, March 29, 2022. Wang Ying | Xinhua News Agency | Getty Images At least 1 million people have been kicked off Medicaid since coverage protections implemented during the Covid-19 pandemic expired in April, according […]
Read More
Updated Covid vaccines need to target XBB omicron variants this fall, FDA staff says
Syringe with Covid-19 vaccine against the XBB Variant. Fight against virus Covid-19 Coronavirus, Vaccination and immunization. Undefined Undefined | Istock | Getty Images U.S. Food and Drug Administration staff on Monday said updated Covid boosters should target XBB omicron subvariants for the upcoming fall and winter vaccination campaign. The U.S. should use a monovalent vaccine […]
Read More
FDA advisors weigh whether Alzheimer’s drug Leqembi should receive full approval
[The stream is scheduled to begin at 10 a.m. ET. Please refresh the page if you don’t see a player above at that time.] A panel of independent advisors to the Food and Drug Administration is meeting Friday to make a recommendation on whether the Alzheimer’s drug Leqembi, made by Eisai and Biogen, should receive […]
Read More
FDA advisors recommend AstraZeneca, Sanofi antibody to protect babies from RSV
Narisara Nami | Moment | Getty Images A panel of independent advisors to the Food and Drug Administration unanimously recommended Thursday that the antibody nirsevimab be approved for use to protect infants from respiratory syncytial virus, the leading cause of hospitalization among newborns. If the FDA approves nirsevimab, the antibody would become the first medical […]
Read More